Medical Care
Global Bronchiectasis Treatment Drug Market Research Report 2025
- Mar 13, 25
- ID: 131563
- Pages: 87
- Figures: 90
- Views: 50
The global market for Bronchiectasis Treatment Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Bronchiectasis Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bronchiectasis Treatment Drug.
The Bronchiectasis Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bronchiectasis Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bronchiectasis Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Grifols
GlaxoSmithKline
Sanofi
Boehringer-Ingelheim
Cadilapharma
Aradigm Corporation
Zambon
Santhera Pharmaceuticals
Bayer
Insmed Inc
Alitair Pharmaceuticals
Polyphor
Kamada Ltd
Segment by Type
Amikacin Sulfate
ARD-3150
CHF-6333
Ciprofloxacin Hydrochloride
Doxofylline
Others
Segment by Application
Offline Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bronchiectasis Treatment Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Bronchiectasis Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bronchiectasis Treatment Drug.
The Bronchiectasis Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bronchiectasis Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bronchiectasis Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Grifols
GlaxoSmithKline
Sanofi
Boehringer-Ingelheim
Cadilapharma
Aradigm Corporation
Zambon
Santhera Pharmaceuticals
Bayer
Insmed Inc
Alitair Pharmaceuticals
Polyphor
Kamada Ltd
Segment by Type
Amikacin Sulfate
ARD-3150
CHF-6333
Ciprofloxacin Hydrochloride
Doxofylline
Others
Segment by Application
Offline Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bronchiectasis Treatment Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bronchiectasis Treatment Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Amikacin Sulfate
1.2.3 ARD-3150
1.2.4 CHF-6333
1.2.5 Ciprofloxacin Hydrochloride
1.2.6 Doxofylline
1.2.7 Others
1.3 Market by Application
1.3.1 Global Bronchiectasis Treatment Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Offline Pharmacy
1.3.3 Online Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bronchiectasis Treatment Drug Market Perspective (2020-2031)
2.2 Global Bronchiectasis Treatment Drug Growth Trends by Region
2.2.1 Global Bronchiectasis Treatment Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Bronchiectasis Treatment Drug Historic Market Size by Region (2020-2025)
2.2.3 Bronchiectasis Treatment Drug Forecasted Market Size by Region (2026-2031)
2.3 Bronchiectasis Treatment Drug Market Dynamics
2.3.1 Bronchiectasis Treatment Drug Industry Trends
2.3.2 Bronchiectasis Treatment Drug Market Drivers
2.3.3 Bronchiectasis Treatment Drug Market Challenges
2.3.4 Bronchiectasis Treatment Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bronchiectasis Treatment Drug Players by Revenue
3.1.1 Global Top Bronchiectasis Treatment Drug Players by Revenue (2020-2025)
3.1.2 Global Bronchiectasis Treatment Drug Revenue Market Share by Players (2020-2025)
3.2 Global Bronchiectasis Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Bronchiectasis Treatment Drug Revenue
3.4 Global Bronchiectasis Treatment Drug Market Concentration Ratio
3.4.1 Global Bronchiectasis Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bronchiectasis Treatment Drug Revenue in 2024
3.5 Global Key Players of Bronchiectasis Treatment Drug Head office and Area Served
3.6 Global Key Players of Bronchiectasis Treatment Drug, Product and Application
3.7 Global Key Players of Bronchiectasis Treatment Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Bronchiectasis Treatment Drug Breakdown Data by Type
4.1 Global Bronchiectasis Treatment Drug Historic Market Size by Type (2020-2025)
4.2 Global Bronchiectasis Treatment Drug Forecasted Market Size by Type (2026-2031)
5 Bronchiectasis Treatment Drug Breakdown Data by Application
5.1 Global Bronchiectasis Treatment Drug Historic Market Size by Application (2020-2025)
5.2 Global Bronchiectasis Treatment Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Bronchiectasis Treatment Drug Market Size (2020-2031)
6.2 North America Bronchiectasis Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Bronchiectasis Treatment Drug Market Size by Country (2020-2025)
6.4 North America Bronchiectasis Treatment Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bronchiectasis Treatment Drug Market Size (2020-2031)
7.2 Europe Bronchiectasis Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Bronchiectasis Treatment Drug Market Size by Country (2020-2025)
7.4 Europe Bronchiectasis Treatment Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bronchiectasis Treatment Drug Market Size (2020-2031)
8.2 Asia-Pacific Bronchiectasis Treatment Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Bronchiectasis Treatment Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Bronchiectasis Treatment Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bronchiectasis Treatment Drug Market Size (2020-2031)
9.2 Latin America Bronchiectasis Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Bronchiectasis Treatment Drug Market Size by Country (2020-2025)
9.4 Latin America Bronchiectasis Treatment Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bronchiectasis Treatment Drug Market Size (2020-2031)
10.2 Middle East & Africa Bronchiectasis Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Bronchiectasis Treatment Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Bronchiectasis Treatment Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Grifols
11.1.1 Grifols Company Details
11.1.2 Grifols Business Overview
11.1.3 Grifols Bronchiectasis Treatment Drug Introduction
11.1.4 Grifols Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.1.5 Grifols Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Bronchiectasis Treatment Drug Introduction
11.2.4 GlaxoSmithKline Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.2.5 GlaxoSmithKline Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Bronchiectasis Treatment Drug Introduction
11.3.4 Sanofi Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.3.5 Sanofi Recent Development
11.4 Boehringer-Ingelheim
11.4.1 Boehringer-Ingelheim Company Details
11.4.2 Boehringer-Ingelheim Business Overview
11.4.3 Boehringer-Ingelheim Bronchiectasis Treatment Drug Introduction
11.4.4 Boehringer-Ingelheim Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.4.5 Boehringer-Ingelheim Recent Development
11.5 Cadilapharma
11.5.1 Cadilapharma Company Details
11.5.2 Cadilapharma Business Overview
11.5.3 Cadilapharma Bronchiectasis Treatment Drug Introduction
11.5.4 Cadilapharma Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.5.5 Cadilapharma Recent Development
11.6 Aradigm Corporation
11.6.1 Aradigm Corporation Company Details
11.6.2 Aradigm Corporation Business Overview
11.6.3 Aradigm Corporation Bronchiectasis Treatment Drug Introduction
11.6.4 Aradigm Corporation Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.6.5 Aradigm Corporation Recent Development
11.7 Zambon
11.7.1 Zambon Company Details
11.7.2 Zambon Business Overview
11.7.3 Zambon Bronchiectasis Treatment Drug Introduction
11.7.4 Zambon Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.7.5 Zambon Recent Development
11.8 Santhera Pharmaceuticals
11.8.1 Santhera Pharmaceuticals Company Details
11.8.2 Santhera Pharmaceuticals Business Overview
11.8.3 Santhera Pharmaceuticals Bronchiectasis Treatment Drug Introduction
11.8.4 Santhera Pharmaceuticals Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.8.5 Santhera Pharmaceuticals Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Bronchiectasis Treatment Drug Introduction
11.9.4 Bayer Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.9.5 Bayer Recent Development
11.10 Insmed Inc
11.10.1 Insmed Inc Company Details
11.10.2 Insmed Inc Business Overview
11.10.3 Insmed Inc Bronchiectasis Treatment Drug Introduction
11.10.4 Insmed Inc Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.10.5 Insmed Inc Recent Development
11.11 Alitair Pharmaceuticals
11.11.1 Alitair Pharmaceuticals Company Details
11.11.2 Alitair Pharmaceuticals Business Overview
11.11.3 Alitair Pharmaceuticals Bronchiectasis Treatment Drug Introduction
11.11.4 Alitair Pharmaceuticals Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.11.5 Alitair Pharmaceuticals Recent Development
11.12 Polyphor
11.12.1 Polyphor Company Details
11.12.2 Polyphor Business Overview
11.12.3 Polyphor Bronchiectasis Treatment Drug Introduction
11.12.4 Polyphor Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.12.5 Polyphor Recent Development
11.13 Kamada Ltd
11.13.1 Kamada Ltd Company Details
11.13.2 Kamada Ltd Business Overview
11.13.3 Kamada Ltd Bronchiectasis Treatment Drug Introduction
11.13.4 Kamada Ltd Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.13.5 Kamada Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bronchiectasis Treatment Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Amikacin Sulfate
1.2.3 ARD-3150
1.2.4 CHF-6333
1.2.5 Ciprofloxacin Hydrochloride
1.2.6 Doxofylline
1.2.7 Others
1.3 Market by Application
1.3.1 Global Bronchiectasis Treatment Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Offline Pharmacy
1.3.3 Online Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bronchiectasis Treatment Drug Market Perspective (2020-2031)
2.2 Global Bronchiectasis Treatment Drug Growth Trends by Region
2.2.1 Global Bronchiectasis Treatment Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Bronchiectasis Treatment Drug Historic Market Size by Region (2020-2025)
2.2.3 Bronchiectasis Treatment Drug Forecasted Market Size by Region (2026-2031)
2.3 Bronchiectasis Treatment Drug Market Dynamics
2.3.1 Bronchiectasis Treatment Drug Industry Trends
2.3.2 Bronchiectasis Treatment Drug Market Drivers
2.3.3 Bronchiectasis Treatment Drug Market Challenges
2.3.4 Bronchiectasis Treatment Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bronchiectasis Treatment Drug Players by Revenue
3.1.1 Global Top Bronchiectasis Treatment Drug Players by Revenue (2020-2025)
3.1.2 Global Bronchiectasis Treatment Drug Revenue Market Share by Players (2020-2025)
3.2 Global Bronchiectasis Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Bronchiectasis Treatment Drug Revenue
3.4 Global Bronchiectasis Treatment Drug Market Concentration Ratio
3.4.1 Global Bronchiectasis Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bronchiectasis Treatment Drug Revenue in 2024
3.5 Global Key Players of Bronchiectasis Treatment Drug Head office and Area Served
3.6 Global Key Players of Bronchiectasis Treatment Drug, Product and Application
3.7 Global Key Players of Bronchiectasis Treatment Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Bronchiectasis Treatment Drug Breakdown Data by Type
4.1 Global Bronchiectasis Treatment Drug Historic Market Size by Type (2020-2025)
4.2 Global Bronchiectasis Treatment Drug Forecasted Market Size by Type (2026-2031)
5 Bronchiectasis Treatment Drug Breakdown Data by Application
5.1 Global Bronchiectasis Treatment Drug Historic Market Size by Application (2020-2025)
5.2 Global Bronchiectasis Treatment Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Bronchiectasis Treatment Drug Market Size (2020-2031)
6.2 North America Bronchiectasis Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Bronchiectasis Treatment Drug Market Size by Country (2020-2025)
6.4 North America Bronchiectasis Treatment Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bronchiectasis Treatment Drug Market Size (2020-2031)
7.2 Europe Bronchiectasis Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Bronchiectasis Treatment Drug Market Size by Country (2020-2025)
7.4 Europe Bronchiectasis Treatment Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bronchiectasis Treatment Drug Market Size (2020-2031)
8.2 Asia-Pacific Bronchiectasis Treatment Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Bronchiectasis Treatment Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Bronchiectasis Treatment Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bronchiectasis Treatment Drug Market Size (2020-2031)
9.2 Latin America Bronchiectasis Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Bronchiectasis Treatment Drug Market Size by Country (2020-2025)
9.4 Latin America Bronchiectasis Treatment Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bronchiectasis Treatment Drug Market Size (2020-2031)
10.2 Middle East & Africa Bronchiectasis Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Bronchiectasis Treatment Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Bronchiectasis Treatment Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Grifols
11.1.1 Grifols Company Details
11.1.2 Grifols Business Overview
11.1.3 Grifols Bronchiectasis Treatment Drug Introduction
11.1.4 Grifols Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.1.5 Grifols Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Bronchiectasis Treatment Drug Introduction
11.2.4 GlaxoSmithKline Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.2.5 GlaxoSmithKline Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Bronchiectasis Treatment Drug Introduction
11.3.4 Sanofi Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.3.5 Sanofi Recent Development
11.4 Boehringer-Ingelheim
11.4.1 Boehringer-Ingelheim Company Details
11.4.2 Boehringer-Ingelheim Business Overview
11.4.3 Boehringer-Ingelheim Bronchiectasis Treatment Drug Introduction
11.4.4 Boehringer-Ingelheim Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.4.5 Boehringer-Ingelheim Recent Development
11.5 Cadilapharma
11.5.1 Cadilapharma Company Details
11.5.2 Cadilapharma Business Overview
11.5.3 Cadilapharma Bronchiectasis Treatment Drug Introduction
11.5.4 Cadilapharma Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.5.5 Cadilapharma Recent Development
11.6 Aradigm Corporation
11.6.1 Aradigm Corporation Company Details
11.6.2 Aradigm Corporation Business Overview
11.6.3 Aradigm Corporation Bronchiectasis Treatment Drug Introduction
11.6.4 Aradigm Corporation Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.6.5 Aradigm Corporation Recent Development
11.7 Zambon
11.7.1 Zambon Company Details
11.7.2 Zambon Business Overview
11.7.3 Zambon Bronchiectasis Treatment Drug Introduction
11.7.4 Zambon Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.7.5 Zambon Recent Development
11.8 Santhera Pharmaceuticals
11.8.1 Santhera Pharmaceuticals Company Details
11.8.2 Santhera Pharmaceuticals Business Overview
11.8.3 Santhera Pharmaceuticals Bronchiectasis Treatment Drug Introduction
11.8.4 Santhera Pharmaceuticals Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.8.5 Santhera Pharmaceuticals Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Bronchiectasis Treatment Drug Introduction
11.9.4 Bayer Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.9.5 Bayer Recent Development
11.10 Insmed Inc
11.10.1 Insmed Inc Company Details
11.10.2 Insmed Inc Business Overview
11.10.3 Insmed Inc Bronchiectasis Treatment Drug Introduction
11.10.4 Insmed Inc Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.10.5 Insmed Inc Recent Development
11.11 Alitair Pharmaceuticals
11.11.1 Alitair Pharmaceuticals Company Details
11.11.2 Alitair Pharmaceuticals Business Overview
11.11.3 Alitair Pharmaceuticals Bronchiectasis Treatment Drug Introduction
11.11.4 Alitair Pharmaceuticals Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.11.5 Alitair Pharmaceuticals Recent Development
11.12 Polyphor
11.12.1 Polyphor Company Details
11.12.2 Polyphor Business Overview
11.12.3 Polyphor Bronchiectasis Treatment Drug Introduction
11.12.4 Polyphor Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.12.5 Polyphor Recent Development
11.13 Kamada Ltd
11.13.1 Kamada Ltd Company Details
11.13.2 Kamada Ltd Business Overview
11.13.3 Kamada Ltd Bronchiectasis Treatment Drug Introduction
11.13.4 Kamada Ltd Revenue in Bronchiectasis Treatment Drug Business (2020-2025)
11.13.5 Kamada Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Bronchiectasis Treatment Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Amikacin Sulfate
Table 3. Key Players of ARD-3150
Table 4. Key Players of CHF-6333
Table 5. Key Players of Ciprofloxacin Hydrochloride
Table 6. Key Players of Doxofylline
Table 7. Key Players of Others
Table 8. Global Bronchiectasis Treatment Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Bronchiectasis Treatment Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Bronchiectasis Treatment Drug Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Bronchiectasis Treatment Drug Market Share by Region (2020-2025)
Table 12. Global Bronchiectasis Treatment Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Bronchiectasis Treatment Drug Market Share by Region (2026-2031)
Table 14. Bronchiectasis Treatment Drug Market Trends
Table 15. Bronchiectasis Treatment Drug Market Drivers
Table 16. Bronchiectasis Treatment Drug Market Challenges
Table 17. Bronchiectasis Treatment Drug Market Restraints
Table 18. Global Bronchiectasis Treatment Drug Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Bronchiectasis Treatment Drug Market Share by Players (2020-2025)
Table 20. Global Top Bronchiectasis Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bronchiectasis Treatment Drug as of 2024)
Table 21. Ranking of Global Top Bronchiectasis Treatment Drug Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Bronchiectasis Treatment Drug Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Bronchiectasis Treatment Drug, Headquarters and Area Served
Table 24. Global Key Players of Bronchiectasis Treatment Drug, Product and Application
Table 25. Global Key Players of Bronchiectasis Treatment Drug, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Bronchiectasis Treatment Drug Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Bronchiectasis Treatment Drug Revenue Market Share by Type (2020-2025)
Table 29. Global Bronchiectasis Treatment Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Bronchiectasis Treatment Drug Revenue Market Share by Type (2026-2031)
Table 31. Global Bronchiectasis Treatment Drug Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Bronchiectasis Treatment Drug Revenue Market Share by Application (2020-2025)
Table 33. Global Bronchiectasis Treatment Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Bronchiectasis Treatment Drug Revenue Market Share by Application (2026-2031)
Table 35. North America Bronchiectasis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Bronchiectasis Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Bronchiectasis Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Bronchiectasis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Bronchiectasis Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Bronchiectasis Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Bronchiectasis Treatment Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Bronchiectasis Treatment Drug Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Bronchiectasis Treatment Drug Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Bronchiectasis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Bronchiectasis Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Bronchiectasis Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Bronchiectasis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Bronchiectasis Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Bronchiectasis Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 50. Grifols Company Details
Table 51. Grifols Business Overview
Table 52. Grifols Bronchiectasis Treatment Drug Product
Table 53. Grifols Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 54. Grifols Recent Development
Table 55. GlaxoSmithKline Company Details
Table 56. GlaxoSmithKline Business Overview
Table 57. GlaxoSmithKline Bronchiectasis Treatment Drug Product
Table 58. GlaxoSmithKline Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 59. GlaxoSmithKline Recent Development
Table 60. Sanofi Company Details
Table 61. Sanofi Business Overview
Table 62. Sanofi Bronchiectasis Treatment Drug Product
Table 63. Sanofi Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 64. Sanofi Recent Development
Table 65. Boehringer-Ingelheim Company Details
Table 66. Boehringer-Ingelheim Business Overview
Table 67. Boehringer-Ingelheim Bronchiectasis Treatment Drug Product
Table 68. Boehringer-Ingelheim Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 69. Boehringer-Ingelheim Recent Development
Table 70. Cadilapharma Company Details
Table 71. Cadilapharma Business Overview
Table 72. Cadilapharma Bronchiectasis Treatment Drug Product
Table 73. Cadilapharma Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 74. Cadilapharma Recent Development
Table 75. Aradigm Corporation Company Details
Table 76. Aradigm Corporation Business Overview
Table 77. Aradigm Corporation Bronchiectasis Treatment Drug Product
Table 78. Aradigm Corporation Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 79. Aradigm Corporation Recent Development
Table 80. Zambon Company Details
Table 81. Zambon Business Overview
Table 82. Zambon Bronchiectasis Treatment Drug Product
Table 83. Zambon Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 84. Zambon Recent Development
Table 85. Santhera Pharmaceuticals Company Details
Table 86. Santhera Pharmaceuticals Business Overview
Table 87. Santhera Pharmaceuticals Bronchiectasis Treatment Drug Product
Table 88. Santhera Pharmaceuticals Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 89. Santhera Pharmaceuticals Recent Development
Table 90. Bayer Company Details
Table 91. Bayer Business Overview
Table 92. Bayer Bronchiectasis Treatment Drug Product
Table 93. Bayer Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 94. Bayer Recent Development
Table 95. Insmed Inc Company Details
Table 96. Insmed Inc Business Overview
Table 97. Insmed Inc Bronchiectasis Treatment Drug Product
Table 98. Insmed Inc Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 99. Insmed Inc Recent Development
Table 100. Alitair Pharmaceuticals Company Details
Table 101. Alitair Pharmaceuticals Business Overview
Table 102. Alitair Pharmaceuticals Bronchiectasis Treatment Drug Product
Table 103. Alitair Pharmaceuticals Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 104. Alitair Pharmaceuticals Recent Development
Table 105. Polyphor Company Details
Table 106. Polyphor Business Overview
Table 107. Polyphor Bronchiectasis Treatment Drug Product
Table 108. Polyphor Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 109. Polyphor Recent Development
Table 110. Kamada Ltd Company Details
Table 111. Kamada Ltd Business Overview
Table 112. Kamada Ltd Bronchiectasis Treatment Drug Product
Table 113. Kamada Ltd Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 114. Kamada Ltd Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. Authors List of This Report
List of Figures
Figure 1. Bronchiectasis Treatment Drug Picture
Figure 2. Global Bronchiectasis Treatment Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Bronchiectasis Treatment Drug Market Share by Type: 2024 VS 2031
Figure 4. Amikacin Sulfate Features
Figure 5. ARD-3150 Features
Figure 6. CHF-6333 Features
Figure 7. Ciprofloxacin Hydrochloride Features
Figure 8. Doxofylline Features
Figure 9. Others Features
Figure 10. Global Bronchiectasis Treatment Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Bronchiectasis Treatment Drug Market Share by Application: 2024 VS 2031
Figure 12. Offline Pharmacy Case Studies
Figure 13. Online Pharmacy Case Studies
Figure 14. Bronchiectasis Treatment Drug Report Years Considered
Figure 15. Global Bronchiectasis Treatment Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Bronchiectasis Treatment Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Bronchiectasis Treatment Drug Market Share by Region: 2024 VS 2031
Figure 18. Global Bronchiectasis Treatment Drug Market Share by Players in 2024
Figure 19. Global Top Bronchiectasis Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bronchiectasis Treatment Drug as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Bronchiectasis Treatment Drug Revenue in 2024
Figure 21. North America Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Bronchiectasis Treatment Drug Market Share by Country (2020-2031)
Figure 23. United States Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Bronchiectasis Treatment Drug Market Share by Country (2020-2031)
Figure 27. Germany Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Bronchiectasis Treatment Drug Market Share by Region (2020-2031)
Figure 35. China Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Bronchiectasis Treatment Drug Market Share by Country (2020-2031)
Figure 43. Mexico Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Bronchiectasis Treatment Drug Market Share by Country (2020-2031)
Figure 47. Turkey Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Grifols Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 51. GlaxoSmithKline Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 52. Sanofi Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 53. Boehringer-Ingelheim Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 54. Cadilapharma Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 55. Aradigm Corporation Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 56. Zambon Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 57. Santhera Pharmaceuticals Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 58. Bayer Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 59. Insmed Inc Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 60. Alitair Pharmaceuticals Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 61. Polyphor Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 62. Kamada Ltd Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Bronchiectasis Treatment Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Amikacin Sulfate
Table 3. Key Players of ARD-3150
Table 4. Key Players of CHF-6333
Table 5. Key Players of Ciprofloxacin Hydrochloride
Table 6. Key Players of Doxofylline
Table 7. Key Players of Others
Table 8. Global Bronchiectasis Treatment Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Bronchiectasis Treatment Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Bronchiectasis Treatment Drug Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Bronchiectasis Treatment Drug Market Share by Region (2020-2025)
Table 12. Global Bronchiectasis Treatment Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Bronchiectasis Treatment Drug Market Share by Region (2026-2031)
Table 14. Bronchiectasis Treatment Drug Market Trends
Table 15. Bronchiectasis Treatment Drug Market Drivers
Table 16. Bronchiectasis Treatment Drug Market Challenges
Table 17. Bronchiectasis Treatment Drug Market Restraints
Table 18. Global Bronchiectasis Treatment Drug Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Bronchiectasis Treatment Drug Market Share by Players (2020-2025)
Table 20. Global Top Bronchiectasis Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bronchiectasis Treatment Drug as of 2024)
Table 21. Ranking of Global Top Bronchiectasis Treatment Drug Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Bronchiectasis Treatment Drug Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Bronchiectasis Treatment Drug, Headquarters and Area Served
Table 24. Global Key Players of Bronchiectasis Treatment Drug, Product and Application
Table 25. Global Key Players of Bronchiectasis Treatment Drug, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Bronchiectasis Treatment Drug Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Bronchiectasis Treatment Drug Revenue Market Share by Type (2020-2025)
Table 29. Global Bronchiectasis Treatment Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Bronchiectasis Treatment Drug Revenue Market Share by Type (2026-2031)
Table 31. Global Bronchiectasis Treatment Drug Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Bronchiectasis Treatment Drug Revenue Market Share by Application (2020-2025)
Table 33. Global Bronchiectasis Treatment Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Bronchiectasis Treatment Drug Revenue Market Share by Application (2026-2031)
Table 35. North America Bronchiectasis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Bronchiectasis Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Bronchiectasis Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Bronchiectasis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Bronchiectasis Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Bronchiectasis Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Bronchiectasis Treatment Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Bronchiectasis Treatment Drug Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Bronchiectasis Treatment Drug Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Bronchiectasis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Bronchiectasis Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Bronchiectasis Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Bronchiectasis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Bronchiectasis Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Bronchiectasis Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 50. Grifols Company Details
Table 51. Grifols Business Overview
Table 52. Grifols Bronchiectasis Treatment Drug Product
Table 53. Grifols Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 54. Grifols Recent Development
Table 55. GlaxoSmithKline Company Details
Table 56. GlaxoSmithKline Business Overview
Table 57. GlaxoSmithKline Bronchiectasis Treatment Drug Product
Table 58. GlaxoSmithKline Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 59. GlaxoSmithKline Recent Development
Table 60. Sanofi Company Details
Table 61. Sanofi Business Overview
Table 62. Sanofi Bronchiectasis Treatment Drug Product
Table 63. Sanofi Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 64. Sanofi Recent Development
Table 65. Boehringer-Ingelheim Company Details
Table 66. Boehringer-Ingelheim Business Overview
Table 67. Boehringer-Ingelheim Bronchiectasis Treatment Drug Product
Table 68. Boehringer-Ingelheim Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 69. Boehringer-Ingelheim Recent Development
Table 70. Cadilapharma Company Details
Table 71. Cadilapharma Business Overview
Table 72. Cadilapharma Bronchiectasis Treatment Drug Product
Table 73. Cadilapharma Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 74. Cadilapharma Recent Development
Table 75. Aradigm Corporation Company Details
Table 76. Aradigm Corporation Business Overview
Table 77. Aradigm Corporation Bronchiectasis Treatment Drug Product
Table 78. Aradigm Corporation Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 79. Aradigm Corporation Recent Development
Table 80. Zambon Company Details
Table 81. Zambon Business Overview
Table 82. Zambon Bronchiectasis Treatment Drug Product
Table 83. Zambon Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 84. Zambon Recent Development
Table 85. Santhera Pharmaceuticals Company Details
Table 86. Santhera Pharmaceuticals Business Overview
Table 87. Santhera Pharmaceuticals Bronchiectasis Treatment Drug Product
Table 88. Santhera Pharmaceuticals Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 89. Santhera Pharmaceuticals Recent Development
Table 90. Bayer Company Details
Table 91. Bayer Business Overview
Table 92. Bayer Bronchiectasis Treatment Drug Product
Table 93. Bayer Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 94. Bayer Recent Development
Table 95. Insmed Inc Company Details
Table 96. Insmed Inc Business Overview
Table 97. Insmed Inc Bronchiectasis Treatment Drug Product
Table 98. Insmed Inc Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 99. Insmed Inc Recent Development
Table 100. Alitair Pharmaceuticals Company Details
Table 101. Alitair Pharmaceuticals Business Overview
Table 102. Alitair Pharmaceuticals Bronchiectasis Treatment Drug Product
Table 103. Alitair Pharmaceuticals Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 104. Alitair Pharmaceuticals Recent Development
Table 105. Polyphor Company Details
Table 106. Polyphor Business Overview
Table 107. Polyphor Bronchiectasis Treatment Drug Product
Table 108. Polyphor Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 109. Polyphor Recent Development
Table 110. Kamada Ltd Company Details
Table 111. Kamada Ltd Business Overview
Table 112. Kamada Ltd Bronchiectasis Treatment Drug Product
Table 113. Kamada Ltd Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 114. Kamada Ltd Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. Authors List of This Report
List of Figures
Figure 1. Bronchiectasis Treatment Drug Picture
Figure 2. Global Bronchiectasis Treatment Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Bronchiectasis Treatment Drug Market Share by Type: 2024 VS 2031
Figure 4. Amikacin Sulfate Features
Figure 5. ARD-3150 Features
Figure 6. CHF-6333 Features
Figure 7. Ciprofloxacin Hydrochloride Features
Figure 8. Doxofylline Features
Figure 9. Others Features
Figure 10. Global Bronchiectasis Treatment Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Bronchiectasis Treatment Drug Market Share by Application: 2024 VS 2031
Figure 12. Offline Pharmacy Case Studies
Figure 13. Online Pharmacy Case Studies
Figure 14. Bronchiectasis Treatment Drug Report Years Considered
Figure 15. Global Bronchiectasis Treatment Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Bronchiectasis Treatment Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Bronchiectasis Treatment Drug Market Share by Region: 2024 VS 2031
Figure 18. Global Bronchiectasis Treatment Drug Market Share by Players in 2024
Figure 19. Global Top Bronchiectasis Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bronchiectasis Treatment Drug as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Bronchiectasis Treatment Drug Revenue in 2024
Figure 21. North America Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Bronchiectasis Treatment Drug Market Share by Country (2020-2031)
Figure 23. United States Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Bronchiectasis Treatment Drug Market Share by Country (2020-2031)
Figure 27. Germany Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Bronchiectasis Treatment Drug Market Share by Region (2020-2031)
Figure 35. China Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Bronchiectasis Treatment Drug Market Share by Country (2020-2031)
Figure 43. Mexico Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Bronchiectasis Treatment Drug Market Share by Country (2020-2031)
Figure 47. Turkey Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Grifols Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 51. GlaxoSmithKline Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 52. Sanofi Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 53. Boehringer-Ingelheim Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 54. Cadilapharma Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 55. Aradigm Corporation Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 56. Zambon Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 57. Santhera Pharmaceuticals Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 58. Bayer Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 59. Insmed Inc Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 60. Alitair Pharmaceuticals Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 61. Polyphor Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 62. Kamada Ltd Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232